Literature DB >> 33429757

The effectiveness and safety of Sun tip-flexible ureterorenoscope for the management of kidney stones: A protocol for systematic review and meta-analysis of randomized controlled trials.

Yuecai Yuan1, Rui Zhong2, Haibiao Lai1, Zhifeng Huang1, Ye Zeng1, Song Wu1, Liang Zhong1.   

Abstract

INTRODUCTION: Kidney stone is one of the urinary system diseases with a high incidence. In this study, we will evaluate the effectiveness and safety of Sun tip-flexible ureterorenoscope treating patients with kidney stone. METHODS AND ANALYSIS: English and Chinese literature about Sun tip-flexible ureterorenoscope treatment for kidney stones published before October 31, 2020 will be systematic searched in PubMed, Embase, Web of Science, Cochrane Library, Open Grey, Clinicaltrials.gov, Chinese Clinical Trial Registry, WANFANG, VIP Chinese Science and Technology Journal Database, CNKI, Chinese biomedical document service system (SinoMed). Only randomized controlled trials (RCTs) of patients with kidney stones will be included. Literature screening, data extraction, and the assessment of risk of bias will be independently conducted by 2 reviewers, and the 3rd reviewer will be consulted if any different opinions existed. Systematic review and meta-analysis will be produced by RevMan 5.3 and Stata 14.0. This protocol reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) statement, and we will report the systematic review by following the PRISMA statement.
RESULTS: The current study is a protocol for systematic review and meta-analysis without results, and data analysis will be carried out after the protocol. We will share our findings in the fourth quarter of 2021.
CONCLUSION: This study will provide recommendations for the effectiveness and safety of Sun tip-flexible ureterorenoscope for patients with kidney stones (KS), which may help to guide clinician. ETHICS AND DISSEMINATION: Ethical approval is not required as the review is a secondary study based on published literature. The results of the study will be published in peer-reviewed publications and disseminated electronically or in print. PROTOCOL REGISTRATION NUMBER: INPLASY2020110099.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33429757      PMCID: PMC7793437          DOI: 10.1097/MD.0000000000023964

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  33 in total

1.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

2.  Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I.

Authors:  Dean Assimos; Amy Krambeck; Nicole L Miller; Manoj Monga; M Hassan Murad; Caleb P Nelson; Kenneth T Pace; Vernon M Pais; Margaret S Pearle; Glenn M Preminger; Hassan Razvi; Ojas Shah; Brian R Matlaga
Journal:  J Urol       Date:  2016-05-27       Impact factor: 7.450

3.  Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial.

Authors:  Eugene Lin; Lin Ho; Mao-Sheng Lin; Min-Ho Huang; Wen-Chi Chen
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

4.  Determinants of quality of life for patients with kidney stones.

Authors:  Karim Bensalah; Altug Tuncel; Amit Gupta; Jay D Raman; Margaret S Pearle; Yair Lotan
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 5.  Dietary salt, urinary calcium, and kidney stone risk.

Authors:  L K Massey; S J Whiting
Journal:  Nutr Rev       Date:  1995-05       Impact factor: 7.110

6.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

7.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

8.  Efficacy and Reliability of Retrograde Intrarenal Surgery in Treatment of Pediatric Kidney Stones.

Authors:  Musa Ekici; Berat Cem Ozgur; Aykut Bugra Senturk; Cemil Aydin; Arzu Akdaglı Ekici; Muhammet Yaytokgil; Mehmet M Baykam
Journal:  Cureus       Date:  2018-12-11

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  [Analgesia with acupuncture in extracorporeal shock wave lithotripsy of kidney stones--first results].

Authors:  J Hodzic; K Golka; S Selinski; H Pourvali; H-J Sommerfeld
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.